Michael Garofalo

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi request reprint The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer
    Michael C Garofalo
    Department of Radiation Oncology, University of Maryland at Baltimore, 22 South Green Street, Baltimore, MD 21201, USA
    Surg Oncol Clin N Am 13:589-604, viii. 2004
  2. ncbi request reprint The case for adjuvant chemoradiation for pancreatic cancer
    Michael Garofalo
    Department of Radiation Oncology, University of Maryland Medical Center, 22 S Greene Street, Baltimore, MD 21201, USA
    Best Pract Res Clin Gastroenterol 20:403-16. 2006
  3. doi request reprint Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers
    Susannah Yovino
    Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Int J Radiat Oncol Biol Phys 79:158-62. 2011
  4. ncbi request reprint Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound
    Susannah Yovino
    Department of Radiation Oncology, University of Maryland School of Medicine, 22 S Greene St, Baltimore, MD 21201, USA
    J Gastrointest Surg 11:36-42. 2007
  5. doi request reprint The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation
    Thomas J MacVittie
    Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, MD 21201, USA
    Health Phys 103:427-53. 2012
  6. ncbi request reprint Radiation oncology emergencies
    Young Kwok
    Department of Radiation Oncology, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA
    Hematol Oncol Clin North Am 20:505-22. 2006
  7. ncbi request reprint Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions
    Michael T Milano
    Department of Cellular and Radiation Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Oncol 28:1141-51. 2006
  8. pmc On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer
    Michael C Garofalo
    Ann Surg 244:332-3; author reply 333. 2006
  9. ncbi request reprint Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm
    William F Regine
    Department of Radiation Oncology, University of Maryland, Baltimore, MD, USA
    Int J Radiat Oncol Biol Phys 68:172-7. 2007
  10. ncbi request reprint Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome
    Michael T Milano
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 59:445-53. 2004

Detail Information

Publications13

  1. ncbi request reprint The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer
    Michael C Garofalo
    Department of Radiation Oncology, University of Maryland at Baltimore, 22 South Green Street, Baltimore, MD 21201, USA
    Surg Oncol Clin N Am 13:589-604, viii. 2004
    ..Implications of the recently completed intergroup study are discussed, modern radiation therapy delivery techniques are reviewed, and suggestions for future trials are made...
  2. ncbi request reprint The case for adjuvant chemoradiation for pancreatic cancer
    Michael Garofalo
    Department of Radiation Oncology, University of Maryland Medical Center, 22 S Greene Street, Baltimore, MD 21201, USA
    Best Pract Res Clin Gastroenterol 20:403-16. 2006
    ..Modern radiotherapy delivery techniques will also be discussed and future trial designs suggested...
  3. doi request reprint Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers
    Susannah Yovino
    Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Int J Radiat Oncol Biol Phys 79:158-62. 2011
    ..Whether these improved dose distributions are associated with decreased toxicity when compared with conventional three-dimensional treatment remains a subject of investigation...
  4. ncbi request reprint Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound
    Susannah Yovino
    Department of Radiation Oncology, University of Maryland School of Medicine, 22 S Greene St, Baltimore, MD 21201, USA
    J Gastrointest Surg 11:36-42. 2007
    ..A standardized method for predicting unresectability in pancreatic cancer has not been defined. We propose a system using CT and endoscopic ultrasound (EUS) to assess patients for unresectable pancreatic cancers...
  5. doi request reprint The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation
    Thomas J MacVittie
    Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, MD 21201, USA
    Health Phys 103:427-53. 2012
    ..Specific and multi-organ medical countermeasures can be assessed for efficacy and interaction during the concomitant evolution of acute and delayed key organ-specific subsyndromes...
  6. ncbi request reprint Radiation oncology emergencies
    Young Kwok
    Department of Radiation Oncology, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA
    Hematol Oncol Clin North Am 20:505-22. 2006
    ..When radiation therapy is used, the total dose and fractionation schedule should be tailored to the disease setting and life expectancy of the patient...
  7. ncbi request reprint Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions
    Michael T Milano
    Department of Cellular and Radiation Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Oncol 28:1141-51. 2006
    ..Building on the present clinical experience, future directions include more directed efforts at reducing toxicity, with better planning software and planning techniques...
  8. pmc On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer
    Michael C Garofalo
    Ann Surg 244:332-3; author reply 333. 2006
  9. ncbi request reprint Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm
    William F Regine
    Department of Radiation Oncology, University of Maryland, Baltimore, MD, USA
    Int J Radiat Oncol Biol Phys 68:172-7. 2007
    ..To determine the maximum tolerated dose of upper abdominal low-dose fractionated radiotherapy (<1.0 Gy per fraction) given in combination with, and as a chemopotentiator for, gemcitabine...
  10. ncbi request reprint Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome
    Michael T Milano
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 59:445-53. 2004
    ..To assess the efficacy and toxicity of intensity-modulated radiotherapy (IMRT) in pancreatic and bile duct (cholangiocarcinoma) malignancies...
  11. ncbi request reprint Primary MALT lymphoma of the gallbladder. Case report
    Matthew Koshy
    Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA
    J Gastrointestin Liver Dis 17:207-10. 2008
    ..When the disease is localized to the gallbladder, primary MALT lymphomas of the gallbladder carry an excellent prognosis, and surgical resection is curative in the majority of cases...
  12. ncbi request reprint Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review
    Johnny Kao
    Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA
    Cancer Treat Rev 29:21-30. 2003
    ..The results of reirradiation in recurrent head and neck cancer and the prognostic factors predicting outcome in this patient population are reviewed...
  13. ncbi request reprint Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer
    Michael C Garofalo
    University of Chicago, Department of Radiation and Cellular Oncology, Chicago, Illinois 60637, USA
    Curr Opin Oncol 14:330-3. 2002
    ..This article provides a rationale for management and reviews recent results of reirradiation...